openPR Logo
Press release

Mastocytosis Treatment Market Size in the 7MM is expected to a significant CAGR by 2032, estimates DelveInsight | Patara Pharma, AB Science, Cogent Biosciences, Inc., JADO Technologies GmbH, Blueprint Medicines Corporation, Telios Pharma Inc., Novartis Ph

02-20-2025 11:55 AM CET | Health & Medicine

Press release from: DelveInisight Business Research

Mastocytosis Drugs Market

Mastocytosis Drugs Market

DelveInsight's "Mastocytosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Mastocytosis, historical and forecasted epidemiology as well as the Mastocytosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Key Takeaways from the Mastocytosis Market Research Report
• In February 2025:- Blueprint Medicines Corporation:- The primary objective of the rollover study is to evaluate the long-term safety of avapritinib in participants who have completed a Blueprint Medicines sponsored study (parent study) and continued to benefit from avapritinib.
• In January 2025:- Cogent Biosciences Inc.:- This is a multi-part, randomized, double-blind, placebo-controlled Phase 2 clinical study comparing the safety and efficacy of bezuclastinib (CGT9486) plus best supportive care (BSC) with placebo plus BSC in patients with nonadvanced systemic mastocytosis (NonAdvSM), including indolent systemic mastocytosis and smoldering systemic mastocytosis, whose symptoms are not adequately controlled by BSC. This study will be conducted in three parts. Patients in Parts 1a, 1b and 2 will receive bezuclastinib or placebo, and may roll over onto Part 3 to receive treatment with bezuclastinib.
• The increase in Mastocytosis Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
• As per DelveInsight analysis, the Mastocytosis Market is anticipated to witness growth at a considerable CAGR.
• The leading Mastocytosis Companies such as Patara Pharma, AB Science, Cogent Biosciences, Inc., JADO Technologies GmbH, Blueprint Medicines Corporation, Telios Pharma Inc., Novartis Pharmaceuticals and others.
• Promising Mastocytosis Pipeline Therapies such as PA101, masitinib, Bezuclastinib Tablets (Formulation A), RAD001 (Everolimus), TF 002, Avapritinib, and others.

Discover which therapies are expected to gra the Mastocytosis Market Share @ Mastocytosis Market Outlook- https://www.delveinsight.com/sample-request/mastocytosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Mastocytosis Overview
Mastocytosis is a rare disorder characterized by an abnormal accumulation of mast cells in various tissues of the body, most commonly the skin, bone marrow, and internal organs. These excess mast cells can release a variety of mediators, such as histamine, leading to a wide range of symptoms, including skin rashes, itching, flushing, abdominal pain, and in severe cases, anaphylaxis. Mastocytosis can manifest in different forms, ranging from cutaneous mastocytosis, which primarily affects the skin, to systemic mastocytosis, which involves multiple organ systems.

Mastocytosis Epidemiology Insights
The epidemiology section of Mastocytosis offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.

Download the report to understand which factors are driving Mastocytosis Epidemiology trends @ Mastocytosis Epidemiological Insights- https://www.delveinsight.com/sample-request/mastocytosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Mastocytosis Drugs Market
The Mastocytosis Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Mastocytosis signaling in Mastocytosis are likely to uncover new therapeutic targets and further expand treatment options for patients.

Mastocytosis Treatment Market Landscape
The Mastocytosis treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Mastocytosis has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.

To know more about Mastocytosis treatment guidelines, visit @ Mastocytosis Treatment Market Landscape- https://www.delveinsight.com/sample-request/mastocytosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Mastocytosis Market Outlook
The report's outlook on the Mastocytosis market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Mastocytosis therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Mastocytosis drug and late-stage pipeline therapy. It assesses their impact based on various factors such as annual therapy costs, inclusion/exclusion criteria, mechanism of action, compliance rates, market demand, patient population growth, covered patient segments, anticipated launch year, competition with other therapies, brand value, and input from key opinion leaders. The analyzed Mastocytosis market data are presented concisely through relevant tables and graphs to offer a clear overview of the market dynamics.

Mastocytosis Drugs Uptake
The drug chapter of the Mastocytosis report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, disadvantages of each drug, as well as the latest news and press releases related to Mastocytosis.

Major Mastocytosis Companies
Patara Pharma, AB Science, Cogent Biosciences, Inc., JADO Technologies GmbH, Blueprint Medicines Corporation, Telios Pharma Inc., Novartis Pharmaceuticals and others.

Learn more about the FDA-approved drugs for Mastocytosis @ Drugs for Mastocytosis Treatment- https://www.delveinsight.com/sample-request/mastocytosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Mastocytosis Market Report
• Coverage- 7MM
• Study Period- 2019-2032
• Mastocytosis Companies- Patara Pharma, AB Science, Cogent Biosciences, Inc., JADO Technologies GmbH, Blueprint Medicines Corporation, Telios Pharma Inc., Novartis Pharmaceuticals and others.
• Mastocytosis Pipeline Therapies- PA101, masitinib, Bezuclastinib Tablets (Formulation A), RAD001 (Everolimus), TF 002, Avapritinib, and others.
• Mastocytosis Market Dynamics: Mastocytosis Market Drivers and Barriers
• Mastocytosis Market Access and Reimbursement, Unmet Needs, and Future Perspectives

Discover more about Mastocytosis Drugs in development @ Mastocytosis Clinical Trials Assessment- https://www.delveinsight.com/sample-request/mastocytosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Key Insights
2. Executive Summary of Mastocytosis
3. Competitive Intelligence Analysis for Mastocytosis
4. Mastocytosis: Market Overview at a Glance
5. Mastocytosis: Disease Background and Overview
6. Patient Journey
7. Mastocytosis Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Mastocytosis Unmet Needs
10. Key Endpoints of Mastocytosis Treatment
11. Mastocytosis Marketed Products
12. Mastocytosis Emerging Therapies
13. Mastocytosis: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Mastocytosis
17. Mastocytosis KOL Views
18. Mastocytosis Market Drivers
19. Mastocytosis Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight

List of the Top Selling Market Research Reports in 2025
intraocular lens market- https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
vulvar cancer market- https://www.delveinsight.com/report-store/vulvar-cancer-pipeline-insight
healthcare competitive benchmarking- https://www.delveinsight.com/consulting/competitive-benchmarking-services
novel drug delivery devices market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
microscopy device market- https://www.delveinsight.com/report-store/microscopy-device-market
phototherapies for psoriasis market- https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-market
urea cycle disorders market- https://www.delveinsight.com/blog/urea-cycle-disorder-market
antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
sepsis market- https://www.delveinsight.com/report-store/sepsis-market-insight
lactose intolerance market- https://www.delveinsight.com/report-store/lactose-intolerance-market
bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
lymphoedema market- https://www.delveinsight.com/report-store/lymphoedema-market
cart pipeline- https://www.delveinsight.com/report-store/cart-cell-therapy-competitive-landscape
dyspepsia market- https://www.delveinsight.com/report-store/functional-dyspepsia-pipeline-insight
total knee arthroplasty market- https://www.delveinsight.com/report-store/knee-reconstruction-devices-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mastocytosis Treatment Market Size in the 7MM is expected to a significant CAGR by 2032, estimates DelveInsight | Patara Pharma, AB Science, Cogent Biosciences, Inc., JADO Technologies GmbH, Blueprint Medicines Corporation, Telios Pharma Inc., Novartis Ph here

News-ID: 3878682 • Views:

More Releases from DelveInisight Business Research

Mulitple System Atrophy Pipeline Accelerates as 22+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
Mulitple System Atrophy Pipeline Accelerates as 22+ Pharma Companies Rigorously …
DelveInsight's "Multiple System Atrophy Pipeline Insight 2026" report provides comprehensive insights about 22+ companies and 24+ pipeline drugs in the Multiple System Atrophy pipeline landscape. It covers the Multiple System Atrophy Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Multiple System Atrophy Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious
Breast Cancer Pipeline Accelerates as 250+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
Breast Cancer Pipeline Accelerates as 250+ Pharma Companies Rigorously Develop D …
DelveInsight's "Breast Cancer Pipeline Insight 2026" report provides comprehensive insights about 250+ Breast Cancer companies and 300+ pipeline drugs in the Breast Cancer pipeline landscape. It covers the Breast Cancer pipeline drugs profiles, including clinical and nonclinical stage products. It also covers the Breast Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover the latest
Short Bowel Syndrome Therapeutics Market (7MM) is expected to grow from USD 2,500 million in 2025 to USD 4,100 Million in 2036, estimates DelveInsight
Short Bowel Syndrome Therapeutics Market (7MM) is expected to grow from USD 2,50 …
DelveInsight's "Short Bowel Syndrome Treatment Market Insights, Epidemiology, and Market Forecast - 2036" report delivers an in-depth understanding of Short Bowel Syndrome, historical and forecasted epidemiology as well as Short Bowel Syndrome market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. Explore the intricate details of the Short Bowel Syndrome Treatment Market Report @ https://www.delveinsight.com/sample-request/short-bowel-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from Short Bowel Syndrome Market
High-grade Glioma (HGG) Market is Projected to Grow Significantly by 2036 Owing to the Launch of Novel Targeted Therapies and Immunotherapies | DelveInsight
High-grade Glioma (HGG) Market is Projected to Grow Significantly by 2036 Owing …
The market dynamics for High-grade Glioma (HGG) are witnessing steady growth driven by the rising incidence of aggressive brain tumors, increasing demand for effective targeted therapies, and growing adoption of advanced immunotherapies and precision medicine approaches. Additionally, the launch of emerging therapies such as DB107-RRV (Denovo Biopharma), MDNA55 (Medicenna Therapeutics), EO2401 (Enterome), and others will further fuel the market. DelveInsight, a leading market research firm, announces the release of its latest

All 5 Releases


More Releases for Mastocytosis

Future Prospects: Key Trends Shaping the Mastocytosis Drug Market Until 2029
The market for mastocytosis drugs is poised for significant expansion as advancements in treatment options and diagnostic capabilities gain momentum. With rising awareness and innovation in managing this rare condition, the industry is set to experience substantial growth through the end of the decade. Let's explore the market's size, key players, evolving trends, and the different segments shaping its future. Projected Market Size and Growth Trajectory for Mastocytosis Drugs The
Mastocytosis Market Expected to Grow to USD 3.4 Billion by 2034
Mastocytosis is a rare disorder characterized by the abnormal accumulation of mast cells in the skin, bone marrow, and other organs. It is broadly classified into cutaneous mastocytosis (CM) and systemic mastocytosis (SM), with systemic forms ranging from indolent to aggressive and mast cell leukemia. Symptoms vary widely, including skin lesions, anaphylaxis, gastrointestinal issues, and bone pain, making diagnosis and treatment complex. Download Full PDF Sample Copy of Market Report @
Mastocytosis Drug Market Landscape 2025: Forecast Data and Growth Strategy Insig …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Mastocytosis Drug Market Through 2025? There has been a robust increase in the mastocytosis drug market size in the past few years. The market is set to expand from $1.07 billion in 2024 to $1.17 billion in 2025, displaying a compound annual
Systemic Mastocytosis Pipeline: Insights into Novel Pipeline Therapies, Key Phar …
DelveInsight's, "Systemic Mastocytosis Pipeline Insight, 2022," report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Systemic Mastocytosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. In the Systemic Mastocytosis pipeline report, detailed description of the
Cutaneous Mastocytosis Market to Eyewitness Stunning Growth by 2027
This Cutaneous Mastocytosis market report provides both theoretical and practical estimations of market variables. The information given here is analyzed to create a complete market research. It seeks to divide the market into parts and sub-sections in order to capture the most recent industry developments. Basics are extremely important in assisting major companies in making business decisions and overcoming obstacles, and this market study seeks to provide these fundamentals. This
Regulatory Experimentation to Catalyse the Cutaneous Mastocytosis Market
Cutaneous Mastocytosis Market 2022-2027 The Cutaneous Mastocytosis Market is expected to climb up the ladder of persistence in the next decade. With various healthcare apps on the anvil, there are also mindfulness apps being tabled. They fall in the category of "Wellness apps". With the world wishing for the post-Covid era to function smoothly, these wellness apps are expected to take the healthcare vertical by storm further. The Cutaneous Mastocytosis Market is